Literature DB >> 14697745

Severe phenotype of chronic granulomatous disease presenting in a female with a de novo mutation in gp91-phox and a non familial, extremely skewed X chromosome inactivation.

Mindy Anderson-Cohen1, Steve M Holland, Doug B Kuhns, Thomas A Fleisher, Li Ding, Sebastian Brenner, Harry L Malech, Joachim Roesler.   

Abstract

Chronic granulomatous disease (CGD) is an inherited immunodeficiency resulting from defects in the multienzyme complex NADPH-oxidase (phagozyte oxidase, phox), which normally produces microbicidal reactive oxygen metabolites (ROM). The reason for our patient's CGD was unusual, as revealed by the following in vitro findings in neutrophils and EBV-transformed B-cells: lack of flavocytochrome b(558) expression, restoration of significant ROM production after transduction with gp91-phox cDNA by a retrovirus vector, an 879G-->A, Trp289-->Stop mutation in one X chromosomal gp91-phox allele, a one-sided paternal X chromosome inactivation, as shown by a lyonization assay at the HUMARA locus, and the result of a dihydrorhodamine 123 flow cytometry assay revealing consistently that 1 in 2500 neutrophils produced ROM at normal levels. Our conclusion: A presumed autosomal form of CGD has been excluded. Instead, a spontaneous mutation in gp91-phox coinciding with an extreme X chromosome inactivation ratio resulted in X-linked CGD in this young woman.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14697745     DOI: 10.1016/j.clim.2003.08.002

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  15 in total

Review 1.  Hematologically important mutations: X-linked chronic granulomatous disease (third update).

Authors:  Dirk Roos; Douglas B Kuhns; Anne Maddalena; Joachim Roesler; Juan Alvaro Lopez; Tadashi Ariga; Tadej Avcin; Martin de Boer; Jacinta Bustamante; Antonio Condino-Neto; Gigliola Di Matteo; Jianxin He; Harry R Hill; Steven M Holland; Caroline Kannengiesser; M Yavuz Köker; Irina Kondratenko; Karin van Leeuwen; Harry L Malech; László Marodi; Hiroyuki Nunoi; Marie-José Stasia; Anna Maria Ventura; Carl T Witwer; Baruch Wolach; John I Gallin
Journal:  Blood Cells Mol Dis       Date:  2010-08-21       Impact factor: 3.039

2.  A female patient with incomplete hemophagocytic lymphohistiocytosis caused by a heterozygous XIAP mutation associated with non-random X-chromosome inactivation skewed towards the wild-type XIAP allele.

Authors:  Xi Yang; Akihiro Hoshino; Takashi Taga; Tomoaki Kunitsu; Yuhachi Ikeda; Takahiro Yasumi; Kenichi Yoshida; Taizo Wada; Kunio Miyake; Takeo Kubota; Yusuke Okuno; Hideki Muramatsu; Yuichi Adachi; Satoru Miyano; Seishi Ogawa; Seiji Kojima; Hirokazu Kanegane
Journal:  J Clin Immunol       Date:  2015-03-07       Impact factor: 8.317

3.  Skewed X inactivation of the normal allele in fully mutated female carriers determines the levels of FMRP in blood and the fragile X phenotype.

Authors:  Raquel Martínez; Victoria Bonilla-Henao; Antonio Jiménez; Miguel Lucas; Carmen Vega; Inmaculada Ramos; Francisco Sobrino; Elizabeth Pintado
Journal:  Mol Diagn       Date:  2005

4.  Residual NADPH oxidase and survival in chronic granulomatous disease.

Authors:  Douglas B Kuhns; W Gregory Alvord; Theo Heller; Jordan J Feld; Kristen M Pike; Beatriz E Marciano; Gulbu Uzel; Suk See DeRavin; Debra A Long Priel; Benjamin P Soule; Kol A Zarember; Harry L Malech; Steven M Holland; John I Gallin
Journal:  N Engl J Med       Date:  2010-12-30       Impact factor: 91.245

5.  Clinical and Molecular Features of Chronic Granulomatous Disease in Mainland China and a XL-CGD Female Infant Patient After Prenatal Diagnosis.

Authors:  Shiyu Wang; Tao Wang; Qingqing Xiang; Min Xiao; Yao Cao; Huan Xu; Shujuan Li; Wen Tian; Xiaodong Zhao; Xuemei Tang; Liping Jiang
Journal:  J Clin Immunol       Date:  2019-08-27       Impact factor: 8.317

6.  Long polymerase chain reaction-based fluorescence in situ hybridization analysis of female carriers of X-linked chronic granulomatous disease deletions.

Authors:  Kelly Claire Simon; Deborah Noack; Julie Rae; John Curnutte; Shireen Sarraf; Valentin Kolev; Jan K Blancato
Journal:  J Mol Diagn       Date:  2005-05       Impact factor: 5.568

7.  Severe X-linked chronic granulomatous disease in two unrelated females.

Authors:  Sylvie Chollet-Martin; Anne Lopez; Catherine Gaud; Dominique Henry; Bertrand Stos; Jamel El Benna; Gaëlle Chedevile; Dominique Gendrel; Marie-Anne Gougerot-Pocidalo; Bernard Grandchamp; Bénédicte Gérard
Journal:  Eur J Pediatr       Date:  2006-11-03       Impact factor: 3.183

8.  X-linked chronic granulomatous disease secondary to skewed X chromosome inactivation in a female with a novel CYBB mutation and late presentation.

Authors:  Eric M Lewis; Manav Singla; Susan Sergeant; Patrick P Koty; Linda C McPhail
Journal:  Clin Immunol       Date:  2008-09-06       Impact factor: 3.969

9.  Clinical Features of Female Taiwanese Carriers with X-linked Chronic Granulomatous Disease from 2004 to 2019.

Authors:  Wen-I Lee; Cheng-Hsun Chiu; Chao-Yi Wu; Yi-Ching Chen; Jing-Long Huang; Li-Chen Chen; Liang-Shiou Ou; Tsung-Chieh Yao; Tang-Her Jaing; Shih-Hsiang Chen; Chi-Jou Liang; Chen-Chen Kang
Journal:  J Clin Immunol       Date:  2021-05-08       Impact factor: 8.317

10.  Copy number variations due to large genomic deletion in X-linked chronic granulomatous disease.

Authors:  Takashi Arai; Tsutomu Oh-ishi; Hideaki Yamamoto; Hiroyuki Nunoi; Junji Kamizono; Masahiko Uehara; Takeo Kubota; Takuya Sakurai; Takako Kizaki; Hideki Ohno
Journal:  PLoS One       Date:  2012-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.